UPDATE : Monday, September 7, 2020
상단여백
Are made-in-Korea Botox products smuggled into China?
The Chinese government has never approved Korean “Botulinum toxin” products...
by Nam Doo-hyun  |  2017-07-10 16:25
라인
Breast cancer therapy Ibrance likely to get insurance benefit
Pfizer’s breast cancer therapy Palbociclib, better known as Ibrance, is lik...
by Nam Doo-hyun  |  2017-07-07 14:26
라인
Is it necessary to write ‘MD’ in license for herb doctors?
To help oriental medicine doctors advance to the United States, it is neces...
by Nam Doo-hyun  |  2017-07-06 17:23
라인
Smaller firms lead domestic stem cell market
Big businesses and small- to medium-sized enterprises (SMEs) account for 17...
by Nam Doo-hyun  |  2017-07-05 13:49
라인
Pompous start, poor showing: R&D report card of oriental medicine
The Traditional Korean Medicine R&D Project, which began with the goal of d...
by Nam Doo-hyun  |  2017-07-05 12:00
라인
A letter to Pfizer CEO Michael Goettler
Dear CEO Michael Goettler,“There was no mention of Ibrance in the question ...
by Nam Doo-hyun  |  2017-07-04 18:57
라인
KISTI present ways to sharpen competitiveness of precision medicine
For precision medicine to take root in Korea, the nation needs to make a mo...
by Nam Doo-hyun  |  2017-06-23 13:35
라인
Why Roche Korea can’t unveil research results of new lung cancer therapy?
Roche Korea is treading carefully in promoting Alecensa (compound: alectini...
by Nam Doo-hyun  |  2017-06-22 16:36
라인
‘Korea needs to develop biomarkers for personalized medical services’
As the biomarker technology remains at a nascent stage in Korea, the indust...
by Nam Doo-hyun  |  2017-06-22 13:24
라인
Sanofi fuels competition in 4-strain flu vaccine market
Competition in the quadrivalent influenza vaccine market will likely become...
by Nam Doo-hyun  |  2017-06-21 11:36
라인
Kwangdong tops pharmaceuticals’ 1Q sales list of health food
Kwangdong Pharmaceutical has recorded the highest sales of functional healt...
by Nam Doo-hyun  |  2017-06-20 18:47
라인
'Bio ventures are for developing new drugs, not making cosmetics'
Bio ventures promoting cosmetic products while claiming to carry the banner...
by Nam Doo-hyun  |  2017-06-19 14:47
라인
Experts call for separate organ to develop bio drugs
The nation needs to set up an independent organization responsible for deve...
by Nam Doo-hyun  |  2017-06-15 13:12
라인
New government set to streamline healthcare R&D projects
The Moon Jae-in administration, which is busy setting up specific strategie...
by Nam Doo-hyun  |  2017-06-15 11:05
라인
Pharmaceutical industry wants to use medical big data at public organizations
Drugmakers are raising their voices to ease regulations so that they can ma...
by Nam Doo-hyun  |  2017-06-14 15:46
라인
Nation needs to develop new drugs to treat senile eye diseases
“Macular degeneration,” changes occurring in macular which results in the v...
by Nam Doo-hyun  |  2017-06-12 12:28
라인
Regulators deem Pfizer’s price for cancer therapy too high
Insurance coverage negotiations for Pfizer’s expensive breast cancer drug, ...
by Nam Doo-hyun  |  2017-06-09 17:31
라인
‘Break global makers’ monopoly on radiotherapy device market’
The domestic market for radiotherapy equipment, for which Korea entirely re...
by Nam Doo-hyun  |  2017-06-08 17:30
라인
Biogen to enter Korean market with new therapy
Global bio industry giant Biogen is highly likely to enter Korea’s market, ...
by Nam Doo-hyun  |  2017-06-07 17:40
라인
Approvals soar for telemedicine SW, equipment
The number of approvals for “U-healthcare gateway” needed for conducting te...
by Nam Doo-hyun  |  2017-06-05 17:18
여백
여백
여백
Back to Top